|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.28 USD | +0.01% |
|
+0.15% | +77.90% |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 06-25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 134.29 | 134.29 | 176.82 |
| Spread/Res. | -0.01% | -0.01% | -24.06% |
| Spread/Supp. | +25.51% | +47.72% | +96.23% |
| Support | 106.99 | 90.9 | 68.43 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- APGE Stock
- Charts Apogee Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
